BeStock  
Stocks › Biotechnology › ABVX

Abivax S.A. ABVX

US equityMarket cap rank #1799Biotechnology
$73.20 −$7.45 (-9.24%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $74.95 +2.39%
Open$79.01
Prev close$80.65
Day range$62.70 – $79.74
Volume14.85M
Market cap$6.41B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-14.9x
CheapRich

Around its usual level · 55th percentile, 5-year average -14.2x

Price / book18.9x
CheapRich

Near the top of its 5-year range · 89th percentile, 5-year average -36.7x

#5131 of 5331 stocks by PB (1 = cheapest)

Price / sales1,560.1x
CheapRich

Above its usual level · 69th percentile, 5-year average 800.5x

#5101 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-36x-23x-10x3xOct '23May '25Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$108.21
Price vs. fair value-32.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 18.93 – -36.66 89% (pricier than usual) #5131 of 5331 (1 = cheapest)
PE -14.86 -22.85 -14.22 55% (pricier than usual) –
PS 1,560.11 183.34 800.52 69% (pricier than usual) #5101 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ABVX.

Sign in to join the discussion.

Scroll to Top